Quantivis LLC Information

We help biotech and pharma teams make smarter, faster, and more confident development decisions. By integrating quantitative medicine strategies—combining data, modeling, and translational insight—we reduce risk, accelerate timelines, and strengthen regulatory and investment confidence to bring novel therapeutics to patients more efficiently. We are a strategic consulting firm with 25 years of leadership in implementing clinical translational pharmacology and model-informed drug development strategies, embedding evidence-based decision-making, and leading therapeutic innovation that bring project, portfolio, and patient value. Our experience spans a wide range of successful accomplishments across large variety of therapeutic modalities in multiple therapeutic areas including advancing multiple assets from preclinical, through development and regulatory approval, into life-cycle management, with contributions to many INDs and 5+ global approvals. We partner with biotech and pharma to embed quantitative medicine into every stage of drug development. Our services include: • Quantitative and Clinical Pharmacology strategy development and implementation • Translational Pharmacology and Human Dose Prediction strategy development and implementation • Dose selection, dose optimization, biomarker strategy and clinical trial design • Regulatory and investor support • Capability building through leadership, vendor oversight, and training Delivered through flexible, fractional, and/or on-demand engagements. Ready to unlock the value of quantitative medicine? Send us a message, or contact our Founder: https://www.linkedin.com/in/sandra-visser-a63b5848/ or visit our website: www.quantivisllc.com